Solid Tumor Testing Market Size to Reach USD 69.13 Billion by 2030 at 7.85% CAGR: Maximize Market Research
Global Solid Tumor Testing Market Valued at USD 40.73 Billion in 2023, Projected to Reach USD 69.13 Billion by 2030 with a 7.85% CAGR as Next-Generation Sequencing, Biomarker Profiling, and Precision Oncology Reshape Cancer Care PUNE, INDIA — The global clinical oncology, molecular diagnostics, and pathology sectors are undergoing a monumental paradigm shift from broad-spectrum systemic chemotherapy toward highly personalized, biomarker-driven cancer therapies. According to a strategic market intelligence report published by Maximize Market Research, the global Solid Tumor Testing Market was valued at USD 40.73 Billion in 2023 and is projected to expand at a compound annual growth rate ( CAGR) of 7.85% , reaching USD 69.13 Billion by 2030 . As global healthcare systems confront increasing incidence rates of solid malignancies—including lung, breast, colorectal, prostate, bladder, liver, ovarian, and brain cancers—molecular testing platforms have become indispensable. Advanced N...